Invivyd, Inc. (IVVD)
2.47
+0.04
(+1.65%)
USD |
NASDAQ |
Dec 31, 16:00
2.55
+0.08
(+3.24%)
Pre-Market: 08:55
Invivyd Cash from Investing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -1.299M |
| Relmada Therapeutics, Inc. | 6.753M |
| Arcellx, Inc. | -20.03M |
| ADMA Biologics, Inc. | -14.37M |
| Cidara Therapeutics, Inc. | -176.47M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.25M |
| Cash from Financing (Quarterly) | 58.31M |
| Free Cash Flow | -80.44M |
| Free Cash Flow Per Share (Quarterly) | -0.0485 |
| Free Cash Flow to Equity (Quarterly) | -7.962M |
| Free Cash Flow to Firm (Quarterly) | -8.25M |
| Free Cash Flow Yield | -24.58% |